SubscribeAll Posts Tagged With: "medical trends"
You’re Probably Missing Out on This $500 Billion Trend
The drug world thought Daniel Vasella was crazy…
As CEO of Swiss drug giant Novartis, Vasella crossed enemy lines. In 2005, he acquired two leading generic drugmakers and bundled them together to create the world’s second-largest generic-drug company… under the Novartis roof.
The industry doubted lucrative brand-name drugs and cheap generic knock-offs could coexist at one company. But last year, Novartis’ generics division brought in about $8 billion, growing sales 25% per year.
Every year, the generics market snowballs bigger. About $12 billion of brand-name sales were lost to generics in 2006… $14 billion in 2007… and $23 billion in…
6Mar2009 | Stansberry and Associates | 0 comments | Continued
Loading ...
